Hong Liu

Title: Innovations in Embolism Materials: The Contributions of Hong Liu

Introduction

Hong Liu is a notable inventor based in Hubei, China. He has made significant contributions to the field of medical materials, particularly in the development of embolism materials for blood vessels. His innovative work has the potential to enhance therapeutic options for patients with tumors in hypervascular and parenchymal visceral organs.

Latest Patents

Hong Liu holds a patent for an embolism material for blood vessels, along with its preparation method and use in drug preparation. The patent details the use of poly(N-isopropylacrylamide-co-butyl methacrylate) in creating an embolism material. This material comprises a dispersion medium that includes an electrolyte, a contrast agent, a pH regulator, and water. The specific concentrations of the polymer, electrolyte, and contrast agent are crucial for its effectiveness, ranging from 5-30 mg/ml, 0.1-30 mg/ml, and 100-350 mg/ml based on iodine, respectively. This innovative embolism material is designed for use in embolization therapy, providing a new avenue for treating tumors.

Career Highlights

Hong Liu is currently associated with Anew-Med Life Science (Wuhan) Co., Ltd. His work at this company focuses on advancing medical technologies and improving patient outcomes through innovative materials. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Hong Liu collaborates with talented professionals, including Haixia Sun and Han Li. These partnerships enhance the research and development process, fostering innovation and the successful implementation of new medical solutions.

Conclusion

Hong Liu's contributions to the field of embolism materials represent a significant advancement in medical technology. His innovative patent and collaborative efforts are paving the way for improved therapeutic options in the treatment of tumors.